H6H
JAZZ icon

Hightower 6M Holding’s Jazz Pharmaceuticals JAZZ Stock Holding History

Hightower 6M Holding’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,466
Closed -$229K – 304
2022
Q2 		$229K Hold
1,466
– – 0.02% 233
2022
Q1 		$228K Buy
+1,466
New +$213K 0.02% 254

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
PCM
Polaris Capital Management Boston, Massachusetts $1.06B AUM 40.82% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Hightower 6M Holding's JAZZ Position: Q3 2022 in Review

Hightower 6M Holding sold out of Jazz Pharmaceuticals (JAZZ) in Q3 2022, closing a stake of 1,466 shares — an estimated $229K sold.

Hightower 6M Holding first reported a position in JAZZ in Q1 2022 and held it in 2 quarters. The position peaked at $229K in Q2 2022. 469 funds tracked by Wall St. Rank hold JAZZ as of Q3 2022.

  • Hightower 6M Holding reported no remaining Jazz Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
  • Hightower 6M Holding sold 1,466 Jazz Pharmaceuticals shares in Q3 2022, an estimated $229K.
  • Hightower 6M Holding first reported a position in Jazz Pharmaceuticals in Q1 2022 and held it in 2 quarters.
  • Hightower 6M Holding's Jazz Pharmaceuticals position peaked at $229K in Q2 2022.
  • 469 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2022.

Based on Hightower 6M Holding's 13F filing for Q3 2022, filed 25 Oct 2022.